These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8300862)

  • 1. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families.
    Hillert J; Käll T; Vrethem M; Fredrikson S; Ohlson M; Olerup O
    J Neuroimmunol; 1994 Feb; 50(1):95-100. PubMed ID: 8300862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and the HLA-D region: linkage and association studies.
    Kellar-Wood HF; Wood NW; Holmans P; Clayton D; Robertson N; Compston DA
    J Neuroimmunol; 1995 May; 58(2):183-90. PubMed ID: 7759607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
    Hillert J; Olerup O
    Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis.
    Fogdell A; Olerup O; Fredrikson S; Vrethem M; Hillert J
    Neurology; 1997 Mar; 48(3):758-62. PubMed ID: 9065561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity.
    Hillert J; Käll T; Olerup O; Söderström M
    Acta Neurol Scand; 1996 Sep; 94(3):161-6. PubMed ID: 8899048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families.
    Eoli M; Pandolfo M; Amoroso A; Salmaggi A; Zaffaroni M; Gasparini P; DiDonato S; Milanese C; Zeviani M
    Eur J Hum Genet; 1995; 3(5):303-11. PubMed ID: 8556305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen studies in multiple sclerosis.
    Hillert J
    Ann Neurol; 1994; 36 Suppl():S15-7. PubMed ID: 8017880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
    Olerup O; Hillert J
    Tissue Antigens; 1991 Jul; 38(1):1-15. PubMed ID: 1926129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
    Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
    Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of HLA in multiple sclerosis: close linkage in multiplex families.
    Tienari PJ; Wikström J; Koskimies S; Partanen J; Palo J; Peltonen L
    Eur J Hum Genet; 1993; 1(4):257-68. PubMed ID: 8081940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
    Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
    Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No linkage or association of a VNTR marker in the junction region of the immunoglobulin heavy chain genes in multiple sclerosis.
    Ligers A; He B; Fogdell-Hahn A; Olerup O; Hillert J
    Eur J Immunogenet; 1997 Aug; 24(4):259-64. PubMed ID: 9306094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis.
    He B; Navikas V; Lundahl J; Söderström M; Hillert J
    J Neuroimmunol; 1995 Dec; 63(2):143-7. PubMed ID: 8550811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of multiple sclerosis. A review.
    Kalman B; Lublin FD
    Biomed Pharmacother; 1999 Sep; 53(8):358-70. PubMed ID: 10554670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic segregation of multiple sclerosis and histocompatibility (HLA) haplotypes.
    Alter M; Quevedo J
    J Neurol; 1979; 222(2):67-74. PubMed ID: 93633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.
    Eldridge R; McFarland H; Sever J; Sadowsky D; Krebs H
    Ann Neurol; 1978 Jan; 3(1):72-80. PubMed ID: 418737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
    Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
    Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor B (BF) allotypes and multiple sclerosis in north-east England.
    Papiha SS; Duggan-Keen M; Roberts DF
    Hum Hered; 1991; 41(6):397-402. PubMed ID: 1797634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.